Gene Abnormalities and Prognosis in Diffuse Large B-cell Lymphoma
NCT04825899 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2021-04-01
Summary
to detect the translocation of c-Myc, Bcl-2 and Bcl-6 by FISH and 481 gene mutation by next generation sequencing and analyze the relationship between this gene abnormalities and the efficacy and prognosis in diffuse large B cell lymphoma.
Conditions
- Diffuse Large B Cell Lymphoma, Gene Mutation
Interventions
- OTHER
-
Sponsors & Collaborators
-
Fudan University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-08
- Primary Completion
- 2022-02-08
- Completion
- 2024-02-08
Countries
- China
Study Locations
More Related Trials
-
The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study
NCT04957901 ·Status: RECRUITING
-
Molecular Epidemiology of Lymphoma Patients
NCT00488553 ·Status: WITHDRAWN
-
The Aim is to Identify Recurrent Genomic Mutations and/or Predisposing Polymorphisms in Patients With Sporadic Cases of Multiple Myeloma
NCT05331313 ·Status: UNKNOWN
-
Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
NCT00003863 ·Status: COMPLETED
-
Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma
NCT05693012 ·Status: UNKNOWN
-
Early Assessment of Lymphoma Treatment Response Using Phased Variant Analysis With Next-Generation Sequencing
NCT06550427 ·Status: RECRUITING
-
Clinical Cohort of Lymphoma Patients in Malawi
NCT02835911 ·Status: RECRUITING
-
S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma
NCT00985699 ·Status: COMPLETED
-
Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM.
NCT01079429 ·Status: TERMINATED
-
Study of Specimens From Young Patients With Neuroblastoma
NCT00958659 ·Status: COMPLETED
-
Use of Plasma ctDNA Methylation Haplotypes in Detecting Local Residual or Lymph Node Metastasis
NCT03868215 ·Status: UNKNOWN
-
Biomarker Research for Personalized Medicine
NCT01488591 ·Status: UNKNOWN
-
Cell-free Circulating DNA in Primary Cutaneous Lymphomas
NCT02883517 ·Status: COMPLETED
-
Optical Genome Mapping in Characterization of Multiple Myeloma
NCT05786105 ·Status: COMPLETED
-
Evaluation of the Humoral and Tumoral Molecular Alteration Profile of Brain Metastases
NCT05848050 ·Status: COMPLETED ·Phase: NA
-
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
NCT02269592 ·Status: RECRUITING
-
13C Pyruvate DNP MR Spectroscopy for Lymphoma Treatment Response Assessment
NCT05600361 ·Status: UNKNOWN ·Phase: NA
-
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell Lymphoma
NCT01563861 ·Status: COMPLETED
-
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
NCT00339963 ·Status: COMPLETED
-
Studying Genes Associated With Non-Hodgkin Lymphoma in Young Patients
NCT01623856 ·Status: COMPLETED
-
Prospective Multi-omics Observational Study of Gynecological Rare Pathological Tumors
NCT05985941 ·Status: NOT_YET_RECRUITING
-
Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS
NCT06559033 ·Status: NOT_YET_RECRUITING
-
Analysis of Molecular Markers of Drug Resistance in Tumor Biopsies From Previously Untreated Aggressive Non-Hodgkin's Lymphoma
NCT00026910 ·Status: COMPLETED
-
Prognostic Value of "CD200" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality
NCT06258629 ·Status: NOT_YET_RECRUITING
-
Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer
NCT00491621 ·Status: TERMINATED ·Phase: NA